I would once again contact NIH for clarification b/c the response goes against the SPECIAL INSTRUCTIONS (which are present b/c they of course devisate from the standard SF 424 instructions) According to the Guidelines for the announcement: "Special Instructions for Other Project Information (Section 4.4 of SF424 (R&R) Application) Item 6. Project Summary/Abstract: Limited to one page. Begin this section by stating the broad Challenge Area and the specific Challenge Topic that this application addresses. Use the following format: This application addresses broad Challenge Area (01) Behavior, Behavioral Change, and Prevention and specific Challenge Topic, 01-GM-104: Mechanisms of Behavior Change Research. Continue with the instructions in the SF424 (R&R) Application Guide." The standard instructions found in the SF424 (R&R) Application Guide for NIH and Other PHS Agencies (which references 30 lines..): under: 4.4 Other Project Information Component "6. Project Summary/Abstract The Project Summary must contain a summary of the proposed activity suitable for dissemination to the public. It should be a self-contained description of the project and should contain a statement of objectives and methods to be employed. It should be informative to other persons working in the same or related fields and insofar as possible understandable to a scientifically or technically literate lay reader. This Summary must not include any proprietary/confidential information. Please click the add attachment button to the right of this field to complete this entry. The first and major component of the Project Summary/Abstract (i. e., “Description”) is a Project Summary. It is meant to serve as a succinct and accurate description of the proposed work when separated from the application. State the application’s broad, long-term objectives and specific aims, making reference to the health relatedness of the project (i.e., relevance to the mission of the agency). Describe concisely the research design and methods for achieving the stated goals. This section should be informative to other persons working in the same or related fields and insofar as possible understandable to a scientifically or technically literate reader. Avoid describing past accomplishments and the use of the first person. Finally, please make every effort to be succinct. This section must be no longer than 30 lines of text, and follow the required font and margin specifications. An abstract which exceeds this allowable length may be flagged as an error by the agency upon submission. This would require a corrective action before the application will be accepted. The attachment must be in PDF format. (See Section 2.6 for additional information on preparing attachments.) 7. Project Narrative Provide Project Narrative in accordance with the announcement and/or ........" ERIN C. DAVIS Grants Development Specialist II Office of Research Guidance, E-275 Wadsworth Center, NYS DOH Empire State Plaza P.O. Box 509 Loading Dock J (use in lieu of PO Box when sending via courier) Albany, NY 12201-0509 (518) 474-6602 (phone) (518) 402-5540 (fax) Joelina Peck <xxxxxx@ASU .EDU> To Sent by: Research xxxxxx@hrinet.org Administration cc List <xxxxxx@hrinet. Subject org> [RESADM-L] Challenge Grant_Question Regarding Abstract Summary 04/22/2009 03:49 PM Please respond to Research Administration Discussion List <xxxxxx@hrinet. org> Hi All, I just learned that that the program summary section of the challenge grants are limited to 30 lines of text? A department staff member emailed NIH and received a confirmation that it is limited to 30 lines of text. I can’t find any notice updates from NIH for RFA-OD-09-003 that address this change and according to the guidelines the limitation listed is 1 page. Has anyone else heard this information? Have you been using the 30 lines of text or has anyone submitted with a one page summary? If there was an update can someone please share? Thanks for any information you can provide! Joelina Peck, CRA Resource Proposal Analyst Sr. Research Management Office The Biodesign Institute at ASU 1001 S. McAllister Avenue Tempe, AZ 85287-5001 (480) 965- 4878 Voice mail (480) 280-0759 Blackberry (480) 965-3552 Fax xxxxxx@asu.edu ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== IMPORTANT NOTICE: This e-mail and any attachments may contain confidential or sensitive information which is, or may be, legally privileged or otherwise protected by law from further disclosure. It is intended only for the addressee. If you received this in error or from someone who was not authorized to send it to you, please do not distribute, copy or use it or any attachments. Please notify the sender immediately by reply e-mail and delete this from your system. Thank you for your cooperation. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================
